Foghorn Therapeutics Announces Presentation at Upcoming 4th Annual Targeted Protein Degradation Summit

NEXT STORY
Cellectis Presents Initial Preclinical Data on Two Novel Gene Therapies for Patients with RAG1 Severe Combined Immunodeficiency (SCID) and Hyper IgE syndrome at ESGCT 2021
PREV STORY
Intuitive Announces Third Quarter Earnings
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aviragen Therapeutics to Host KOL Meeting on HRV Infections on October 13, 2016 in New York

ATLANTA, Oct. 10, 2016 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ:AVIR), a pharmaceutical company ...

author_avatar
NASDAQ Market News

VBL Therapeutics to Present at Upcoming Conferences in June

TEL AVIV, Israel, May 24, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

author_avatar
NASDAQ Market News

Dr. Deborah Dunsire bliver ny administrerende direktør for Lundbeck

Valby, Denmark, 2. juli 2018 - H. Lundbeck A/S (Lundbeck) har i dag offentliggjort, ...

author_avatar
NASDAQ Market News